PROACT is a Prospective Master Protocol for a Cohort Study Focused on Evaluating the Implementation of Integrated Proactive Supportive Care Pathways at Gustave Roussy

ConditionAny Cancer

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorGustave Roussy, Cancer Campus, Grand Paris

About this trial

PROACT is a prospective master protocol for a cohort study focused on evaluating the implementation of integrated proactive pathways of supportive care.

This is an observational cohort study in the context of a quality-of-care initiative.

It will be evaluated by its impact on patient's distress measured by the NCCN's Distress thermometer at 12 weeks after entering the pathway.

Eligibility criteria

Qualifiers

Histological confirmation of cancer (any cancer type, any stage)

Age ≥ 18 years old

Received an integrated supportive care need assessment.

Sign the consent form for the PROACT study.

Disqualifiers

Absence or inability of written consent from the patient.

Does not understand or speak French.

Trial design

Treatments tested in this trial

Supportive Care Pathway

Treatment groups

700 Participants

are divided into 1 treatment group

Sponsors and collaborators

Gustave Roussy, Cancer Campus, Grand Paris

Lead sponsor

Source ClinicalTrials.gov